Immobilization of enzymes on human tissue or erythrocytes |
| I claim: 1. A method for immobilizing an enzyme on tissue or erythrocytes comprising the steps of ... |
|
Free-flowing, high density, agglomerated vitamin A powder compositions |
| OF THE INVENTION Free-flowing high density agglomerates suitable for direct compression into ... |
|
Spray dried vitamin E powder |
| The embodiments of the invention in which an exclusive property or privilege is claimed are defined ... |
|
Dry stabilized microemulsified omega-three acid-containing oils |
| The marine animal oil to be microemulsified may be derived from any desired marine animal source. A... |
|
Anti-ulcer composition |
| OF THE INVENTION The present invention provides an improved composition for ulcer curative/ulcer ... |
|
Pediatric effervescent dosage form |
| OF THE PREFERRED EMBODIMENT An oral dosage form according to one embodiment of the present ... |
|
Defoaming composition |
| OF THE INVENTION The preferred fluid, nonaqueous, antifoaming or defoaming compound prepared as a ... |
|
Fire-resistant styrene polymer foams |
| OF THE INVENTION In accordance with the invention, a variety of expandable thermoplastic ... |
|
Tissue processing method |
| I claim: 1. A method of processing a tissue specimen, comprising the steps of suspending the ... |
|
|
Drain source protected MNOS transistor and method of manufacture
| Details |
Inventors: Blaha, Franklyn C.; Cricchi, James R.; White, Marvin H.;
Assignee: The United States of America as represented by the Secretary of the Air (Washington, DC)
Primary Examiner: Wojciechowicz; Edward J.
Assistant Examiner:
Attorney, Agent or Firm: Rusz; Joseph E., Matthews, Jr.; Willard R.
An improved drain source protected MNOS transistor is realized by means of a fabrication technique that permits independent control of memory and nonmemory parameters. Self alignment of memory regions during fabrication is achieved by using nitride masking for gate oxidation. Independent control of memory and nonmemory parameters derives from a device configuration in which protected regions consist exclusively of gate oxide and silicon nitride is present only in the memory regions. Transistor radiation hardening is also achieved by elimination of the nitride layer above the device's thin silicon dioxide regions. |
|
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT A partial sectional view of a conventional drain source protected MNOS transistor is shown in FIG. 1 of the drawings. It comprises an N type silicon mesa 4 deposited in a sapphire substrate (not shown). Drain region 6 and source region 5 are established by P+ implantation. The mesa is covered with a layer 7 of silicon dioxide and a layer 8 of silicon nitride. The structure also includes gate electrode 9 and source and drain electrode (not shown). In the standard drain source protect MNOS memory transistor shown in FIG. 1 the deposited nitride layer 8 overlaps the thick oxide protected non-memory regions. The thickness of the nitride layer 8 and the charge at the nitride thick oxide interface both affect the threshold of this non-memory region. Since the operating characteristics of the drain source protected memory transistor depend on both the memory and non-memory characteristics, it is desirable to have independent control of their processing parameters. This is accomplished by a method of creating a drain source protected memory structure where the memory nitride is present only in the memory section of the device. In addition, the process is self-aligning such that the thermal gate oxide is grown in all regions other than the memory section. The process of the invention is hereinafter described having reference to FIGS. 2-9. Having reference now to FIG. 2, a silicon mesa 11 is fabricated on a substrate member 10. Substrate member 10 is of electrically insulating material such as sapphire. A source region 12 and a drain region 13 are established by P+ implantation and a 20-30 A layer 15 of tunneling or memory oxide is grown over the mesa. A 300 A layer 14 of memory silicon nitride is then deposited over the tunneling oxide layer. A 2000 - 3000 A masking silox layer 16 is then deposited and etched to leave silox in the memory regions as shown in FIG. 3. The silicon nitride and tunneling oxide layers are then chemically etched and the silox is stripped to leave the isolated memory regions shown in FIG
|
| Related patents |
|
|
CMOS integrated devices in seeded islands
The low power consumption of integrated circuits fabricated in CMOS has made such structures the norm for future designs. Unfortunately, the conventional use of wells ...
|
|
|
Junction-type field-effect transistor and its manufacture
What is claimed is: 1. A junction field effect transistor which comprises a semiconductor body having a major surface, a surface-adjacent semiconductor layer of a first ...
|
|
|
Analgesic mixture of nalbuphine and ibuprofen
OF THE INVENTION Nalbuphine, which has the chemical name (-)-17-(cyclobutylmethyl)-4,5.alpha.-epoxymorphinan-3,6.alpha.,14-triol, and its preparation are described in U....
|
|
|
Phthalidyl apovincaminate with cerebral eubolic activity
I claim: 1. The compound, 13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo(3,2,1-de)pyrido(3,2,1-ij)(1, 5)naphthyridin-12-phthalidine carboxylate, having the formula ##STR5#...
|
|
|
Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
What is claimed is: 1. A method of preventing alpha-methyl-para-tyrosine crystalluria in a human being who is being treated with a therapeutically effective amount of ...
|
|
|
Treatment of the acute after-effects resulting from alcohol ingestion
I claim: 1. A method for treating the acute after-effects of alcohol ingestion which comprises administering to a person who had ingested alcohol an effective amount of ...
|
|
|
Method of treating abstinence syndrome with cycloaklyltriazoles
What is claimed is: 1. A method of treating symptons of nicotine abstinence syndrome comprising, administering to a mammal which has nicotine abstinence syndrome an ...
|
|
|
Treatment of neurotransmitter-linked drug abuse
OF THE INVENTION The Biel patent describes numerous phenylalkylhydrazines, their preparation, and uses. Their principal suggested use is as psychotherapeutics, ...
|
|
|
Method of treating cognitive and related neural behavioral problems
OF THE INVENTION The novel compounds of the invention are in general obtainable as white, yellow or tan crystalline solids having characteristic melting points and ...
|
|
|
Quinoline derivatives as antagonists of leukotriene D.sub.4
We claim: 1. A compound of the formula ##STR15## where: A is O or S; D is O, S, NR.sub.1, ##STR16## or a chemical bond E is a chemical bond or ##STR17## a is 0-2; b is 0-...
|
|
|